Skip to main content

Advertisement

Log in

Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to characterize the computed tomography (CT) findings of pseudolithiasis and investigate the outcomes and natural history in adult patients receiving CTRX therapy.

Methods

A total of 17 patients were diagnosed with CTRX-associated biliary pseudolithiasis on CT between April 2013 and March 2017. The medical records, characteristics, complications, treatment options, and outcomes of these patients were examined. Serial CT images and the form, density, and location of pseudolithiasis were reviewed by two radiologists.

Results

Of the 17 patients with CTRX-associated pseudolithiasis, seven were men and ten were women. The median patient age was 78 years (range 31–88 years). The median interval from CTRX administration to the diagnosis of pseudolithiasis was 10 days (range 4–32 days). The CT findings of pseudolithiasis included a sludge pattern (11 patients [64.7%]), stone pattern (two patients [11.8%]), and stone plus sludge pattern (four patients [23.5%]). Seven patients (41.2%) showed gall bladder enlargement along with a common bile duct (CBD) stone. Two patients with CBD stones underwent endoscopic CBD stone removal. The median time to pseudolithiasis resolution after CTRX cessation was 69 days.

Conclusion

The high-density sludge pattern is the most common typical CT finding of CTRX-associated pseudolithiasis in adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Schaad U, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet. 1988;332:1411–3.

    Article  Google Scholar 

  2. Cometta A, Gallot-Lavallée-Villars S, Iten A, et al. Incidence of gallbladder lithiasis after ceftriaxone treatment. J Antimicrob Chemother. 1990;25:689–95.

    Article  CAS  Google Scholar 

  3. Heim-Duthoy KL, Caperton EM, Pollock R, et al. Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother. 1990;34:1146–9.

    Article  CAS  Google Scholar 

  4. Kassner EG. Drug-related complications in infants and children: imaging features. AJR Am J Roentgenol. 1991;157:1039–49.

    Article  CAS  Google Scholar 

  5. Lopez AJ, O'Keefe P, Morrissey M, et al. Ceftriaxone-induced cholelithiasis. Ann Intern Med. 1991;115:712–4.

    Article  CAS  Google Scholar 

  6. Kirejczyk W, Crowe H, Mackay I, et al. Disappearing “gallstones”: biliary pseudolithiasis complicating ceftriaxone therapy. AJR Am J Roentgenol. 1992;159:329–30.

    Article  CAS  Google Scholar 

  7. Ko CW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med. 1999;130:301–11.

    Article  CAS  Google Scholar 

  8. Alehossein M, Sotoudeh K, Nasoohi S, et al. Ceftriaxone induced biliary pseudolithiasis in children: report of 14 cases. Iran J Pediatr. 2008;18:31–7.

    Google Scholar 

  9. Palanduz A, Yalçın I, Tonguç E, et al. Sonographic assessment of ceftriaxone associated biliary pseudolithiasis in children. J Clin Ultrasound. 2000;28:166–8.

    Article  CAS  Google Scholar 

  10. Riccabona M, Kerbl R, Schwinger W, et al. Ceftriaxone-induced cholelithiasis—a harmless side-effect? Klin Padiatr. 1993;205:421–3.

    Article  CAS  Google Scholar 

  11. Shuichi A. A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction. IDCases [Internet]. 2017;9:62–4.

    Article  Google Scholar 

  12. Nakajima H, Ota S, Hirose T, et al. Ceftriaxone-associated cholelithiasis in adult patients with bacterial meningitis. J Infect Dis Ther [Internet]. 2014;2(5):161.

    Google Scholar 

  13. Besim H, Arslan K. Ceftriaxone associated acute cholecystitis. Arch Balk Med Union. 2016;51:258–60.

    Google Scholar 

  14. Khurram D, Shamban L, Kornas R, et al. Marked Direct hyperbilirubinemia due to ceftriaxone in an adult with sickle cell disease. Case Rep Gastrointest Med [Internet]. 2015;2015:462165.

    PubMed  PubMed Central  Google Scholar 

  15. Prince JS, Senac MO. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Pediatr Radiol. 2003;33:648–51.

    Article  Google Scholar 

  16. Barakos JA, Ralls P, Lapin SA, et al. Cholelithiasis: evaluation with CT. Radiology. 1987;162:415–8.

    Article  CAS  Google Scholar 

  17. Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. Gastroenterology. 1990;99:1772–8.

    Article  CAS  Google Scholar 

  18. Brogard J, Blickle J, Jehl F, et al. High biliary elimination of ceftriaxone in man. Int J Clin Pharmacol Ther Toxicol. 1988;26:167–72.

    CAS  PubMed  Google Scholar 

  19. Schaad UB, Suter S, Gianella-Borradori A, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med. 1990;322:141–7.

    Article  CAS  Google Scholar 

  20. Kimata T, Kaneko K, Takahashi M, et al. Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis. Pediatr Nephrol. 2012;27:605–9.

    Article  Google Scholar 

  21. Palanivelu C, Jategaonkar P, Rangarajan M, et al. “Pseudo” cholelithiasis: sequelae of minimally invasive cholecystectomy with maximum surprise—an unusual case. Endoscopy. 2009;41:E186–187.

    Article  Google Scholar 

  22. Papadopoulou F, Efremidis S, Karyda S, et al. Incidence of ceftriaxone associated gallbladder pseudolithiasis. Acta Paediatr. 1999;88:1352–5.

    Article  CAS  Google Scholar 

  23. Murata S, Aomatsu T, Yoden A, et al. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone associated pseudolithiasis. Pediatr Int. 2015;57:942–6.

    Article  CAS  Google Scholar 

  24. Hung WY, Lanfranco OA. Contemporary review of drug-induced pancreatitis: a different perspective. World J Gastrointest Pathophysiol. 2014;5:405–15.

    Article  Google Scholar 

  25. Cohen D, Appel GB, Scully B, et al. Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis. Antimicrob Agents Chemother. 1983;24:529–32.

    Article  CAS  Google Scholar 

  26. Robertson FM, Crombleholme TM, Barlow SE, et al. Ceftriaxone choledocholithiasis. Pediatrics. 1996;98:133–5.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rika Yoshida.

Ethics declarations

Conflict of interest

All authors have no conflict of interest to declare.

Ethical approval

This study was approved by the institutional review board of our institution.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yoshida, R., Yoshizako, T., Katsube, T. et al. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults. Jpn J Radiol 37, 826–831 (2019). https://doi.org/10.1007/s11604-019-00893-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-019-00893-5

Keywords

Navigation